tm logo
OCULAR THERAPEUTIX
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 18 Apr 2024

Last Applicant/ Owned by

24 Crosby Drive

Bedford

MA

01730

Serial Number

97401659 filed on 09th May 2022

Registration Number

N/A

Correspondent Address

Matthew P. Hintz, Esq.

LOWENSTEIN SANDLER LLP

ONE LOWENSTEIN DRIVE

ROSELAND,NJ 07068

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

"OCULAR"

OCULAR THERAPEUTIX

Research and development in the pharmaceutical and biopharmaceutical fields; Development of pharmaceutical and biopharmaceutical preparations, inserts, implants, and medicines; Pharmaceutical and biopharmaceutical products development "OCULAR" Color is not claimed as a feature of the mark. OCULAR THERAPEUTIC Pharmaceuticals for treatment of ophthalmic diseases and conditions; Ophthalmic preparRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development in the pharmaceutical and biopharmaceutical fields; Development of pharmaceutical and biopharmaceutical preparations, inserts, implants, and medicines; Pharmaceutical and biopharmaceutical products development


First Use Date in General

31st Aug 2009

First Use Date in Commerce

31st Aug 2009

Class [005]
Pharmaceutical Products


Pharmaceuticals for treatment of ophthalmic diseases and conditions; Ophthalmic preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions; Medical inserts namely, implantable intravitreal drug delivery devices sold filled with ophthalmic pharmaceutical preparations for treating glaucoma, dry eye disease, macular degeneration, and lowering intraocular pressure; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, and macular degeneration; Pharmaceutical preparations for the treatment of lowering intraocular pressure; Medical insert, namely, implantable intravitreal drug delivery devices sold filled with pharmaceutical preparations in the nature of dexamethasone for the treatment of eye diseases and conditions; Medical insert, namely, implantable intravitreal drug delivery devices sold filled with pharmaceutical preparations in the nature of dexamethasone for post-op pain and inflammation of the eye, and itching associated with allergic conjunctivitis


First Use Date in General

31st Aug 2009

First Use Date in Commerce

31st Aug 2009

Mark Details


Serial Number

No 97401659

Mark Type

No Service Mark

Attorney Docket Number

No 39810.20

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.07.21 -

Diamonds that are completely or partially shaded

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.05 -

Horizontal line(s), band(s) or bar(s)

26.17.13 -

Letters or words underlined and/or overlined by one or more strokes or lines

27.03.01 -

Geometric figures forming letters or numerals, including punctuation

Description of Design Search

The mark consists of the word "OCULAR" in a stylized font with a larger, stylized letter "O", which is positioned above a horizontal line, and the stylized word "THERAPEUTIX" in a stylized font, which is positioned below the horizontal line. A shaded diamond forms the dot above the lower case letter "I" in the word "THERAPEUTIX".

Legal History


Show more

Status DateAction Taken
15th Apr 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12th Apr 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
12th Apr 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
12th Apr 2024TEAS/EMAIL CORRESPONDENCE ENTERED
03rd Apr 2024NON-FINAL ACTION WRITTEN
03rd Apr 2024NON-FINAL ACTION E-MAILED
03rd Apr 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
06th Mar 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
06th Mar 2024TEAS/EMAIL CORRESPONDENCE ENTERED
04th Mar 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED